Table 3 Fatty acid profile of the encapsulated oils and the daily dose of PUFAs consumed by each intervention arm
Fatty acid profile of dietary supplements (area%) | PUFAs provided in dietary supplements by arm (g/day) | |||||||
|---|---|---|---|---|---|---|---|---|
Common name | Fatty acid | Corn | Borage | Echium | Fish | CO | BO* | FO |
Myristic | C14:0 | 0 | 0 | 0 | 5.8 | |||
Palmitic | C16:0 | 10.8 | 6.5 | 7.8 | 17.1 | |||
Palmitoleic | C16:1 n-7 | 0 | 0 | 0.0 | 7.0 | |||
Stearic | C18:0 | 2.8 | 3.3 | 5.0 | 4.1 | |||
Oleic | C18:1 n-9 | 29.8 | 9.6 | 18.1 | 11.5 | |||
Vaccenic | C18:1 n-11 | 0 | 0.4 | 0 | 3.0 | |||
Linoleic (LA) | C18:2 n-6 | 54.2 | 22.1 | 18.6 | 1.9 | 3.96 | 1.80 | 0.48 |
Gamma-linoleic (GLA) | C18:3 n-6 | 0 | 41.0 | 9.7 | 0.3 | 0 | 1.65 | 0.05 |
Alpha-linoleic (ALA) | C18:3 n-3 | 0.8 | 0.2 | 28.0 | 1.2 | 0.06 | 1.90 | 0.23 |
Gondoic | C20:1 n-9 | 0.2 | 5.6 | 0 | 0.5 | |||
Stearidonic (SDA) | C18:4 n-3 | 0.1 | 0 | 12.2 | 4.5 | <0.01 | 0.83 | 0.86 |
Dihommo-γ-linolenic (DGLA) | C20:3 n-6 | 0 | 0 | 0 | 0.1 | |||
Behenic | C22:0 | 0.1 | 0.3 | 0 | 1.3 | |||
Arachidonic (ARA) | C20:4 n-6 | 0.2 | 0.1 | 0 | 0 | |||
Erucic | C22:1 n-9 | 0 | 4.3 | 0.1 | 0 | |||
Eicosopentaenoic (EPA) | C20:5 n-3 | 0.1 | 0 | 0 | 18.0 | <0.01 | 0 | 3.58 |
Nervonic | C24:1 n-9 | 0 | 3.2 | 0.1 | 0.9 | |||
Docosapentaenoic (DPA) | C22:5 n-3 | 0 | 0 | 0 | 2.1 | |||
Docosahexaenoic (DHA) | C22:6 n-3 | 0 | 0 | 0 | 12.3 | 0 | 0 | 2.44 |
Others | 0.5 | 0.9 | 0 | 1.2 | ||||